Fortis Healthcare Limited

NSE FORTIS.NS

Fortis Healthcare Limited EBIT Margin for the year ending March 31, 2024: 14.12%

Fortis Healthcare Limited EBIT Margin is 14.12% for the year ending March 31, 2024, a -2.63% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Fortis Healthcare Limited EBIT Margin for the year ending March 31, 2023 was 14.50%, a -25.85% change year over year.
Fortis Healthcare Limited EBIT Margin for the year ending March 31, 2022 was 19.55%, a 403.39% change year over year.
Fortis Healthcare Limited EBIT Margin for the year ending March 31, 2021 was 3.88%, a -58.75% change year over year.
Fortis Healthcare Limited EBIT Margin for the year ending March 31, 2020 was 9.42%, a 131.51% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NSE: FORTIS.NS

Fortis Healthcare Limited

CEO	Dr. Ashutosh Raghuvanshi
IPO Date	May 9, 2007
Location	India
Headquarters	Tower A
Employees	12,088
Sector	Healthcare
Industries Hospitals & Clinics 3D Printing Biotechnology Dental Care Drugstores & Retail Pharmacies Medical Instruments Pharmaceuticals Telehealth

Description

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetes/endocrinology, emergency medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties. As of March 31, 2022, it operated a network of 26 hospitals with approximately 4,300 operational beds. The company also operates approximately 426 diagnostics centers and laboratories; and 2,550 collection centers. The company was incorporated in 1996 and is based in Gurugram, India.

Key trends

Past 5 years